Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Red Hot Eli Lilly Rolls the DICE With Its Latest Biotech Takeover: https://www.marketbeat.com/logos/articles/med_20230621083044_red-hot-eli-lilly-rolls-the-dice-with-its-latest-b.jpg
Red Hot Eli Lilly Rolls the DICE With Its Latest Biotech Takeover

Like other mature drug manufacturers, Eli Lilly and Company (NYSE: LLY) is banking on innovative biotechnology platforms to drive its next growth phase. 

On Tuesday, the nearly 150-year

AutoZone And Why It Will Soon Be A $3,000 Stock: https://www.marketbeat.com/logos/articles/med_20230621081639_autozone-and-why-it-will-soon-be-a-3000-stock.jpg
AutoZone And Why It Will Soon Be A $3,000 Stock

Sometimes a dodgy earnings report can be a blessing in disguise. A revenue miss in last month's fiscal Q3 report for AutoZone Inc (NYSE: AZO) sent their shares down more than 10%, upsetting a

Range-Bound FedEx Delivers More Bad News For Stocks: https://www.marketbeat.com/logos/articles/med_20230621071222_chart-fdx-6212024.png
Range-Bound FedEx Delivers More Bad News For Stocks

FedEx’s (NYSE: FDX) Q4 report isn’t bad per se but is a sign of the times that suggests the economy and the S&P 500 will move sideways and not significantly upward over the next few quarters. The

Can Barbie and the New MCU Rescue Mattel Stock?: https://www.marketbeat.com/logos/articles/med_20230618155643_chart-mat2.jpg
Can Barbie and the New MCU Rescue Mattel Stock?

Family entertainment company Mattel, Inc. (NYSE: MAT) stock has languished in 2023, up 2% on the year, underperforming the S&P 500 index, up 15%. The upcoming Barbie movie scheduled to release in

Insider Trading Activity (Form 4 Filings): What is Form 4?: https://www.marketbeat.com/logos/articles/med_20230620115650_form-4-filing.png
Insider Trading Activity (Form 4 Filings): What is Form 4?

When it comes to gaining an edge in the market, few tactics are as controversial and captivating as buying or selling securities based on privileged information. However, the Securities and

Insider Trading Activity (Form 4 Filings): What is Form 4?: https://www.marketbeat.com/logos/articles/med_20230620115650_form-4-filing.png
Insider Trading Activity (Form 4 Filings): What is Form 4?

When it comes to gaining an edge in the market, few tactics are as controversial and captivating as buying or selling securities based on privileged information. However, the Securities and

Insider Trading Activity (Form 4 Filings): What is Form 4?: https://www.marketbeat.com/logos/articles/med_20230620115650_form-4-filing.png
Insider Trading Activity (Form 4 Filings): What is Form 4?

When it comes to gaining an edge in the market, few tactics are as controversial and captivating as buying or selling securities based on privileged information. However, the Securities and

Is ESG Investing Dead? Fund Outflows Signal Tough Times: https://www.marketbeat.com/logos/articles/med_20230620095523_chart-pep-6202023.png
Is ESG Investing Dead? Fund Outflows Signal Tough Times

ESG investing is not dead, but ESG investing as an investment thesis might be. Fund outflows from ESG-related funds topped 75% in 2022 and have only worsened. The trend is not limited to the US

Is ESG Investing Dead? Fund Outflows Signal Tough Times: https://www.marketbeat.com/logos/articles/med_20230620095523_chart-pep-6202023.png
Is ESG Investing Dead? Fund Outflows Signal Tough Times

ESG investing is not dead, but ESG investing as an investment thesis might be. Fund outflows from ESG-related funds topped 75% in 2022 and have only worsened. The trend is not limited to the US

Is ESG Investing Dead? Fund Outflows Signal Tough Times: https://www.marketbeat.com/logos/articles/med_20230620095523_chart-pep-6202023.png
Is ESG Investing Dead? Fund Outflows Signal Tough Times

ESG investing is not dead, but ESG investing as an investment thesis might be. Fund outflows from ESG-related funds topped 75% in 2022 and have only worsened. The trend is not limited to the US

Is ESG Investing Dead? Fund Outflows Signal Tough Times: https://www.marketbeat.com/logos/articles/med_20230620095523_chart-pep-6202023.png
Is ESG Investing Dead? Fund Outflows Signal Tough Times

ESG investing is not dead, but ESG investing as an investment thesis might be. Fund outflows from ESG-related funds topped 75% in 2022 and have only worsened. The trend is not limited to the US

e.l.f. Beauty on a Shelf: Consolidating for the Next Leg Up?: https://www.marketbeat.com/logos/articles/med_20230620091233_elf.jpg
e.l.f. Beauty on a Shelf: Consolidating for the Next Leg Up?

The chart on cosmetics company e.l.f. Beauty, Inc. (NYSE: ELF) can be described in one word — gorgeous.

The surging mid-cap is riding an eight-month winning streak that, absent a -1% September

The Most Upgraded Stocks In Q2: https://www.marketbeat.com/logos/articles/med_20230620084755_chart-msft-nvda-6202023.png
The Most Upgraded Stocks In Q2

The Q2 earnings reporting season is about to be unleashed, making now an excellent time to look at which stocks the analysts are paying attention to. Among the many ways to find this information

The Most Upgraded Stocks In Q2: https://www.marketbeat.com/logos/articles/med_20230620084755_chart-msft-nvda-6202023.png
The Most Upgraded Stocks In Q2

The Q2 earnings reporting season is about to be unleashed, making now an excellent time to look at which stocks the analysts are paying attention to. Among the many ways to find this information

The Most Upgraded Stocks In Q2: https://www.marketbeat.com/logos/articles/med_20230620084755_chart-msft-nvda-6202023.png
The Most Upgraded Stocks In Q2

The Q2 earnings reporting season is about to be unleashed, making now an excellent time to look at which stocks the analysts are paying attention to. Among the many ways to find this information

The Most Upgraded Stocks In Q2: https://www.marketbeat.com/logos/articles/med_20230620084755_chart-msft-nvda-6202023.png
The Most Upgraded Stocks In Q2

The Q2 earnings reporting season is about to be unleashed, making now an excellent time to look at which stocks the analysts are paying attention to. Among the many ways to find this information

Industrials Shine As Ametek, Cintas, Eaton Trade At New Highs: https://www.marketbeat.com/logos/articles/med_20230620082342_industrials-shine-as-ametek-cintas-eaton-trade-at.jpg
Industrials Shine As Ametek, Cintas, Eaton Trade At New Highs

Sure, everyone knows about the sky-high valuations of Nvidia Corp. (NASDAQ: NVDA) and other techs as the Technology Select Sector SPDR Fund (NYSEARCA: XLK) has advanced 20.99% in the past three

NVIDIA vs. AMD: How To Decide Which Is The Better Stock For You: https://www.marketbeat.com/logos/articles/med_20230620075506_nvidia-vs.jpg
NVIDIA vs. AMD: How To Decide Which Is The Better Stock For You

Any of our readers who were around for the incredible bull years of 2018 and 2019, and indeed through much of the pandemic rally, will remember the epic runs of both NVIDIA Corp (NASDAQ: NVDA) and

NVIDIA vs. AMD: How To Decide Which Is The Better Stock For You: https://www.marketbeat.com/logos/articles/med_20230620075506_nvidia-vs.jpg
NVIDIA vs. AMD: How To Decide Which Is The Better Stock For You

Any of our readers who were around for the incredible bull years of 2018 and 2019, and indeed through much of the pandemic rally, will remember the epic runs of both NVIDIA Corp (NASDAQ: NVDA) and

NVIDIA vs. AMD: How To Decide Which Is The Better Stock For You: https://www.marketbeat.com/logos/articles/med_20230620075506_nvidia-vs.jpg
NVIDIA vs. AMD: How To Decide Which Is The Better Stock For You

Any of our readers who were around for the incredible bull years of 2018 and 2019, and indeed through much of the pandemic rally, will remember the epic runs of both NVIDIA Corp (NASDAQ: NVDA) and

Medical Stocks Waters, Agilent, Illumina Show Growth Potential: https://www.marketbeat.com/logos/articles/med_20230620074442_medicals-stocks-waters-agilent-illumina-show-growt.jpg
Medical Stocks Waters, Agilent, Illumina Show Growth Potential

Investors seeking growth often have no choice other than paying up for a stock with strong potential. However, there are some stocks that appear to be trading at low valuations relative to their

Medical Stocks Waters, Agilent, Illumina Show Growth Potential: https://www.marketbeat.com/logos/articles/med_20230620074442_medicals-stocks-waters-agilent-illumina-show-growt.jpg
Medical Stocks Waters, Agilent, Illumina Show Growth Potential

Investors seeking growth often have no choice other than paying up for a stock with strong potential. However, there are some stocks that appear to be trading at low valuations relative to their

Medical Stocks Waters, Agilent, Illumina Show Growth Potential: https://www.marketbeat.com/logos/articles/med_20230620074442_medicals-stocks-waters-agilent-illumina-show-growt.jpg
Medical Stocks Waters, Agilent, Illumina Show Growth Potential

Investors seeking growth often have no choice other than paying up for a stock with strong potential. However, there are some stocks that appear to be trading at low valuations relative to their